Regulatory Expectations for CAPA Documentation and Follow-Through
Regulatory Expectations for CAPA Documentation and Follow-Through Regulatory Expectations for CAPA Documentation and Follow-Through In the context of pharmaceutical clinical trials, the integration of Corrective and Preventive Actions (CAPA) with Good Clinical Practice (GCP) findings is essential for ensuring compliance and overcoming regulatory scrutiny. This article outlines the step-by-step expectations regarding CAPA documentation and follow-through,…
Read More “Regulatory Expectations for CAPA Documentation and Follow-Through” »